Literature DB >> 24798742

Generic imatinib: the real-deal or just a deal?

Vikram Mathews1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24798742     DOI： 10.3109/10428194.2014.921299

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

1.  Meeting the needs of CML patients in resource-poor countries.

Authors:  Hemant Malhotra; Jerald Radich; Pat Garcia-Gonzalez
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Chronic myeloid leukemia patients call for quality and consistency when generics are introduced to treat their cancer.

Authors:  J Geissler; G Sharf; J Cugurovic; R Padua; Š Narbutas; M Remic; V Venkatesh
Journal:  Leukemia       Date:  2016-08-03       Impact factor: 11.528

3.  Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach.

Authors:  Daniel A Arber; Robert P Hasserjian; Attilio Orazi; Vikram Mathews; Andrew W Roberts; Charles A Schiffer; Anne Stidsholt Roug; Mario Cazzola; Hartmut Döhner; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2022-02-25       Impact factor: 13.265
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.